Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

⭐️Exploring the Tricuspid Valve: The Next Frontier? 🚀 Understanding Atrial vs. Ventricular Functional TR & its Impact on Outcomes. Tune in for my interview with Dr. Maria Korber, senior author of today's #JACCINT publication to delve deeper👇 📖 Full Text: 🧵 Check out the comments below for key study...

11,199 Aufrufe • vor 2 Jahren •via X (Twitter)

1 Kommentare

Profilbild von Umair Khalid
Umair Khalidvor 2 Jahren

✴️Summary points✴️ 🧿Atrial Functional TR (A-FTR) vs Non-Atrial Functional TR (NA-FTR) 🧿Multicenter study examining 1-yr outcomes (165 consecutive patients undergoing Transcatheter Tricuspid Annuloplasty (TTVA)) 🧿62 A-FTR vs 103 NA-FTR patients. Latter had more RV remodeling 🫀 🧿After TTVA, TR grade ≤ II was more frequently observed in A-FTR. 🧿1-year mortality was ↓ in A-FTR (6.5 vs 23.8%, p = 0.011) 🧿No significant difference in HF hospitalizations (13.3% vs 22.7%, p = 0.19) 2/2

Ähnliche Videos

👇EPS and Ventricular Stimulation Testing in the Diagnosis of Narrow Complex Tachycardia: Understanding VA Conduction👇 For #EP_Fellows — simple tricks packed with valuable information! Electrophysiology is logical. Understanding is better than memorizing!!! 👉 Ventriculoatrial (VA) Conduction Patterns: A. VA Dissociation (even with isoproterenol) → Rules out AVRT and AVNRT → Likely diagnosis: Atrial Tachycardia B. VA Conduction with Earliest CS Activation in CS 1/2 → Suggests AVRT with a left lateral accessory pathway C. VA Conduction with Earliest CS Activation in CS 9/10 C.1 Decremental VA Conduction (progressive slowing conduction) → Rules out AVRT → Likely diagnosis: AVNRT or Atrial Tachycardia C.2 Non-decremental VA Conduction → Suggests AVRT with a right-sided or septal accessory pathway #EPeeps This post is part of a collaboration with Nadica Trajkovska If you find this content helpful, please let us know, we can continue exploring further steps of the EPS workflow together 🙏🙏 Philipp Sommer Stephan H. Winnik Christian Sohns Martin Braun Moneeb Khalaph Maxim Didenko, MD PhD FESC FEHRA Dr. Andreas Roeschl Arnel Carmona Pedram Milan Koštek ECG Challenge ALBERTO ALFIE Arab HRS - Heart Rhythm Society The Heart Koichi Nagashima@EP Univ. Ablation School Matters of the Heart 🫀 Gregor Nageler JMC Young DGK AGEP Johnson & Johnson MedTech | Electrophysiology @JNJ_ch Abbott Medtronic BostonSci Cardiology #CardioTwitter Arash Arya

El Hamriti Mustapha

19,782 Aufrufe • vor 1 Jahr

My God… what have they done💔 🚨 Impact of Childhood Vaccination on Short and Long-Term Chronic Health Outcomes in Children: A Birth Cohort Study • Aaron Siri and Del Bigtree met with Dr. Zervos, a pro-vaccine researcher involved in clinical trials, to propose a study comparing health outcomes of vaccinated versus unvaccinated children. • The study was a large-scale analysis of children enrolled at Henry Ford Medical Center from 2000 to 2016, tracked from birth onward. • The study compared unvaccinated children to those who received one or more of the Childhood vaccines, using actual medical records for data. 🔻 Unvaccinated Children: - ZERO Brain dysfunction - ZERO diabetes - ZERO behavioral problems - ZERO learning disabilities - ZERO intellectual disabilities - ZERO tics - ZERO psychological disabilities 🔻 Vaccinated Children: • Asthma: 4.29 times higher in vaccinated children. •• Acute and chronic Ear Infections: 600% more likely with a vaccinated child ••• Atopic disease: 3.03 times higher. •••• Autoimmune disease: 5.96 times higher •••••Neurological Disorders: 300-616% increase in vaccinated children — ADHD, Autism, Behavioral Disability, Developmental Delay, Learning Disability, Intellectual Disability, Speech Disorder 🔻 The study was never published because its findings contradicted the prevailing narrative that vaccines are universally safe. Dr. Zervos and the research team refused to publish due to concerns about job security and making doctors uncomfortable, despite acknowledging the study’s findings.

MJTruthUltra

642,551 Aufrufe • vor 1 Jahr

1. CDC scientists colluded to cover up a relationship between the timing of the MMR vaccine and autism in African Americans that was first discovered in November of 2001. Rather than reporting the results to the public, all data regarding this relationship were destroyed at a secret meeting held some time in August/September of 2002. This fact has been affirmed via an affidavit given by Dr. Thompson to Rep. Bill Posey in September, 2014. 2. Dr. Thompson attempted to warn the CDC Director at the time, Dr. Julie Gerberding, regarding this relationship, prior to the February 2004 Institute of Medicine meeting on vaccines and autism. Rather than allowing Dr. Thompson to present the information at this meeting, Dr. Gerberding replaced him as a speaker with Dr. Frank Destefano, current director of the CDC’s Immunization Safety Office, where he presented fraudulent results regarding the MMR vaccine and autism. Dr. Thompson was put on administrative leave and was threatened that he would be fired due to “insubordination.” 3. When Dr. Thompson attempted to leave the CDC later that same year, he was given a $24,000 retention bonus. Dr. Thompson’s impression of the timing of this bonus, in light of disciplinary actions taken against him earlier that year, is that CDC officials were “buying his silence” through controlling his actions as a CDC employee. 4. Dr. Thompson has published two papers linking thimerosal exposure in infant vaccines to tics in boys (Thompson et al. 2007 and Barile et al. 2012). CDC fraudulently maintains on their website that “There is no evidence of harm caused by the low doses of thimerosal in vaccines, except for minor reactions like redness and swelling at the injection site.” ( The tic result was also affirmed in the earlier CDC publication by Verstraeten et al. (2003) and the Andrews et al. (2004) publication. 5. CDC pressured Dr. Thompson to downplay the tic result of his analysis in his 2007 paper. He was instructed to deemphasize the tic result by the CDC’s Chief Science Officer, Dr. Tanja Popovic, by emphasizing that the “major finding of the study” was “there is NO associations (sic) of thimerosal exposure with the great majority of the outcomes.” Dr. Popovic also instructed Dr. Thompson to interpret any negative outcomes as “chance findings.” 6. CDC also pressured Dr. Thompson to withhold publication of his 2012 paper which reported a relationship between thimerosal and tics. Dr. Ed Travathan, head of the CDC’s National Center for Birth Defects and Developmental Disabilities, stated in an April 27, 2009 memo to him that the analysis was sound except for the tic results and that they should be omitted from the publication. Since the tic result was the only result that had a consistent negative relationship with thimerosal exposure, it seemed that Dr. Thompson’s superiors were specifically concerned that thimerosal’s safety and use not be questioned. As an epidemiologist, Dr. Thompson was justifiably concerned and critical of the CDC’s action to approve the paper for publication only after the CDC took the extraordinary step of adding an expert in tics to water down the paper to state, “This finding should be interpreted with caution due to limitations in the measurement of tics and the limited biological plausibility regarding a causal relationship"

Jessica Rojas 🇺🇸💪

251,372 Aufrufe • vor 3 Jahren